Mojtahedzadeh Mojtaba, Ahmadi Arezoo, Mahmoodpoor Ata, Beigmohammadi Mohammad Taghi, Abdollahi Mohammad, Khazaeipour Zahra, Shaki Fatemeh, Kuochaki Bizhan, Hendouei Narjes
Department of Pharmacotherapy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Department of Anesthesiology and Intensive Care, School of Medicine, Tehran University of Medical Science and Health Services, Tehran, Iran.
J Res Med Sci. 2014 Sep;19(9):867-74.
Oxidative stress processes play an important role in the pathogenesis of secondary brain injury after traumatic brain injury (TBI). Hypertonic saline (HTS) has advantages as being preferred osmotic agent, but few studies investigated oxidant and antioxidant effects of HTS in TBI. This study was designed to compare two different regimens of HTS 5% with mannitol on TBI-induced oxidative stress.
Thirty-three adult patients with TBI were recruited and have randomly received one of the three protocols: 125 cc of HTS 5% every 6 h as bolus, 500 cc of HTS 5%as infusion for 24 h or 1 g/kg mannitol of 20% as a bolus, repeated with a dose of 0.25-0.5 g/kg every 6 h based on patient's response for 3 days. Serum total antioxidant power (TAP), reactive oxygen species (ROS) and nitric oxide (NO) were measured at baseline and daily for 3 days.
Initial serum ROS and NO levels in patients were higher than control(6.86± [3.2] vs. 1.57± [0.5] picoM, P = 0.001, 14.6± [1.6] vs. 7.8± [3.9] mM, P = 0.001, respectively). Levels of ROS have decreased for all patients, but reduction was significantly after HTS infusion and mannitol (3. 08 [±3.1] to 1.07 [±1.6], P = 0.001, 5.6 [±3.4] to 2.5 [±1.8], P = 0.003 respectively). During study, NO levels significantly decreased in HTS infusion but significantly increased in mannitol. TAP Levels had decreased in all patients during study especially in mannitol (P = 0.004).
Hypertonic saline 5% has significant effects on the oxidant responses compared to mannitol following TBI that makes HTS as a perfect therapeutic intervention for reducing unfavorable outcomes in TBI patients.
氧化应激过程在创伤性脑损伤(TBI)后继发性脑损伤的发病机制中起重要作用。高渗盐水(HTS)作为首选的渗透剂具有优势,但很少有研究探讨HTS在TBI中的氧化和抗氧化作用。本研究旨在比较两种不同方案的5%HTS与甘露醇对TBI诱导的氧化应激的影响。
招募33例成年TBI患者,随机接受三种方案之一:每6小时静脉推注125 cc 5%HTS、24小时输注500 cc 5%HTS或静脉推注1 g/kg 20%甘露醇,根据患者反应每6小时重复给予0.25 - 0.5 g/kg剂量,持续3天。在基线和3天内每天测量血清总抗氧化能力(TAP)、活性氧(ROS)和一氧化氮(NO)。
患者初始血清ROS和NO水平高于对照组(分别为6.86±[3.2]对1.57±[0.5]皮摩尔,P = 0.001;14.6±[1.6]对7.8±[3.9]毫摩尔,P = 0.001)。所有患者的ROS水平均下降,但HTS输注和甘露醇治疗后下降显著(分别从3.08[±3.1]降至1.07[±1.6],P = 0.001;从5.6[±3.4]降至2.5[±1.8],P = 0.003)。研究期间,HTS输注组NO水平显著下降,而甘露醇组显著升高。研究期间所有患者的TAP水平均下降,尤其是甘露醇组(P = 0.004)。
与甘露醇相比,5%高渗盐水对TBI后的氧化应激反应有显著影响,这使得HTS成为减少TBI患者不良结局的理想治疗干预措施。